Literature DB >> 30193961

An integrated study on TFs and miRNAs in colorectal cancer metastasis and evaluation of three co-regulated candidate genes as prognostic markers.

Elaheh Eskandari1, Frouzandeh Mahjoubi1, Jamshid Motalebzadeh2.   

Abstract

Molecular alterations that occur in cancer have the potential to be considered as either cancer biomarkers or targeted therapies or even both. In the presented study, we aimed to elucidate the gene regulatory network of metastatic colorectal cancer using data acquired from microarrays to reach the most common DEGs in colorectal cancer metastasis and find their possible regulatory mechanism by DETFs and DEmiRs. In this regards, seven microarray datasets were employed to assess the most important DEGs, DETFs and DEmiRs in colorectal cancer metastasis. Afterward, GRN based on DETFs and DEmiRs were constructed. Also ARACNE algorithm was used to construct an accurate GRN. GRN was analyzed structurally and then, two DETFs (LEF1 and ETV4) and a less-well known DEG (FABP6) by real time qRT-PCR in 50 patients with colorectal cancer were quantified. The constructed GRN highlighted the importance of some DETFs and DEmiRs in colorectal cancer metastasis. Interestingly the gene expression analysis by qRT-PCR on three candidate genes (LEF1, ETV4 and FABP6) indicated that the three genes were co-expressed in tumor samples, and were significantly associated with metastasis in colorectal cancer. Therefore, our experimental results proved a part of our comprehensive data analysis and system biology results. In summary, according to our empirical study we found the importance of three candidate genes as the potent prognostic factors in colorectal cancer metastasis. Also our study in a holistic insight on gene regulatory mechanism revealed the importance of some gene regulatory factors (DETFs and DEmiRs) and their potential as prognostic factors and/or targets in molecular targeted therapies in colorectal cancer.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Colorectal cancer metastasis; DETFs; DEmiRs; ETV4; FABP6; GRN; Hippo signaling pathway; LEF1; Prognosis; Target therapy; Wnt signaling pathway

Mesh:

Substances:

Year:  2018        PMID: 30193961     DOI: 10.1016/j.gene.2018.09.003

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  9 in total

1.  MicroRNA-125b regulates Th17/Treg cell differentiation and is associated with juvenile idiopathic arthritis.

Authors:  Zhi-Dan Fan; Qian Cao; Na Huang; Le Ma; Hui-Hui Ma; Ya-Yuan Zhang; Hai-Guo Yu; Guo-Ping Zhou
Journal:  World J Pediatr       Date:  2019-05-17       Impact factor: 2.764

2.  Transcription factors linked to the molecular signatures in the development of hepatocellular carcinoma on a cirrhotic background.

Authors:  Jamshid Motalebzadeh; Elaheh Eskandari
Journal:  Med Oncol       Date:  2021-09-01       Impact factor: 3.064

Review 3.  Mechanism-Centric Approaches for Biomarker Detection and Precision Therapeutics in Cancer.

Authors:  Christina Y Yu; Antonina Mitrofanova
Journal:  Front Genet       Date:  2021-08-02       Impact factor: 4.772

4.  Identification of a non-classical three-dimensional nuclear localization signal in the intestinal fatty acid binding protein.

Authors:  Mariana Suárez; Lucía Canclini; Adriana Esteves
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

5.  ETV4 plays a role on the primary events during the adenoma-adenocarcinoma progression in colorectal cancer.

Authors:  Aline Simoneti Fonseca; Anelisa Ramão; Matheus Carvalho Bürger; Jorge Estefano Santana de Souza; Dalila Lucíola Zanette; Greice Andreotti de Molfetta; Luiza Ferreira de Araújo; Rafaela de Barros E Lima Bueno; Graziela Moura Aguiar; Jessica Rodrigues Plaça; Cleidson de Pádua Alves; Anemari Ramos Dinarte Dos Santos; Daniel Onofre Vidal; Gyl Eanes Barros Silva; Rodrigo Alexandre Panepucci; Fernanda Maris Peria; Omar Feres; José Joaquim Ribeiro da Rocha; Marco Antonio Zago; Wilson Araújo Silva
Journal:  BMC Cancer       Date:  2021-03-01       Impact factor: 4.430

6.  Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment.

Authors:  Min Luo; Yan Lin; Rong Liang; Yongqiang Li; Lianying Ge
Journal:  J Inflamm Res       Date:  2021-08-28

7.  Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.

Authors:  Lu Zhang; Ruiting Fu; Ping Liu; Lijun Wang; Weihua Liang; Hong Zou; Wei Jia; Lin Tao
Journal:  J Ovarian Res       Date:  2021-11-04       Impact factor: 4.234

8.  A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma.

Authors:  Meng Yuan; Koeun Shong; Xiangyu Li; Sajda Ashraf; Mengnan Shi; Woonghee Kim; Jens Nielsen; Hasan Turkez; Saeed Shoaie; Mathias Uhlen; Cheng Zhang; Adil Mardinoglu
Journal:  Cancers (Basel)       Date:  2022-03-19       Impact factor: 6.639

9.  Low expression of miR-138 inhibit the proliferation, migration and invasion of colorectal cancer and affect patient survival by targeting SIRT1.

Authors:  Xianwu Kang; Bin Kong; Qiang Chen; Shipeng Zhao
Journal:  Transl Cancer Res       Date:  2021-07       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.